Page 11234..10..»

The Promise of Induced Pluripotent Stem Cells (iPSCs …

By Sykes24Tracey

Charles A. Goldthwaite, Jr., Ph.D

To Read More: The Promise of Induced Pluripotent Stem Cells (iPSCs …
categoriaIPS Cell Therapy commentoComments Off on The Promise of Induced Pluripotent Stem Cells (iPSCs … | dataSeptember 7th, 2017
Read All

Medical imaging Wikipedia IPS Cell Therapy IPS Cell …

By Sykes24Tracey

This article is about imaging techniques and modalities for the human body.

To Read More: Medical imaging Wikipedia IPS Cell Therapy IPS Cell …
categoriaIPS Cell Therapy commentoComments Off on Medical imaging Wikipedia IPS Cell Therapy IPS Cell … | dataSeptember 5th, 2017
Read All

Cellular Therapy – The World Leader in Stem Cell Technology

By daniellenierenberg

iPSCells Represent a Superior Approach iPS cell-derived cardiomyocyte patch demonstrates spontaneous and synchronized contractions after 4 days in culture. One of the greatest promises of human stem cells is to transform these early-stage cells into treatments for devastating diseases

To Read More: Cellular Therapy – The World Leader in Stem Cell Technology
categoriaIPS Cell Therapy commentoComments Off on Cellular Therapy – The World Leader in Stem Cell Technology | dataSeptember 5th, 2017
Read All

This Week In Neuroscience News 8/31/17 – ReliaWire

By Sykes24Tracey

This weeks roundup of recent developments in neuroscience kicks off with a study from MIT, where engineers have devised a way to automate the process of monitoring neurons in a living brain using a computer algorithm that analyzes microscope images and guides a robotic arm to the target cell. In the above image, a pipette guided by a robotic arm approaches a neuron identified with a fluorescent stain. Neurosurgeons at the Center for iPS Cell Research and Application, Kyoto University

To Read More: This Week In Neuroscience News 8/31/17 – ReliaWire
categoriaIPS Cell Therapy commentoComments Off on This Week In Neuroscience News 8/31/17 – ReliaWire | dataSeptember 3rd, 2017
Read All

Monkeys With Parkinson’s Disease Successfully Treated With Human Stem Cell Transplants – Technology Networks

By LizaAVILA

Monkeys show reduced Parkinsonian symptoms following a donor-matched iPS cell-based therapy.

To Read More: Monkeys With Parkinson’s Disease Successfully Treated With Human Stem Cell Transplants – Technology Networks
categoriaIPS Cell Therapy commentoComments Off on Monkeys With Parkinson’s Disease Successfully Treated With Human Stem Cell Transplants – Technology Networks | dataSeptember 1st, 2017
Read All

Xeno-free Cell Culture Medium for Regenerative Medicine Research – Technology Networks

By NEVAGiles23

Stem cells and genome editing offer exciting opportunities within regenerative medicine. However, any clinical application of stem cells requires strict regulation to ensure that the cells are not exposed to animal derived products. StemFit Basic02 is a xeno-free, defined medium for human pluripotent stem cell (hiPSC) culture that offers an effective solution for regenerative medicine research.

To Read More: Xeno-free Cell Culture Medium for Regenerative Medicine Research – Technology Networks
categoriaIPS Cell Therapy commentoComments Off on Xeno-free Cell Culture Medium for Regenerative Medicine Research – Technology Networks | dataSeptember 1st, 2017
Read All

Xeno-free cell culture medium for regenerative medicine research – Scientist Live

By daniellenierenberg

Stem cells and genome editing offer exciting opportunities within regenerative medicine. However, any clinical application of stem cells requires strict regulation to ensure that the cells are not exposed to animal derived products.

To Read More: Xeno-free cell culture medium for regenerative medicine research – Scientist Live
categoriaIPS Cell Therapy commentoComments Off on Xeno-free cell culture medium for regenerative medicine research – Scientist Live | dataSeptember 1st, 2017
Read All

Reprogrammed cells relieve Parkinson’s symptoms in trials – Nature.com

By LizaAVILA

B. Bick, . Poindexter, UT Med.

To Read More: Reprogrammed cells relieve Parkinson’s symptoms in trials – Nature.com
categoriaIPS Cell Therapy commentoComments Off on Reprogrammed cells relieve Parkinson’s symptoms in trials – Nature.com | dataAugust 31st, 2017
Read All

Center for Embryonic Cell and Gene Therapy | Center for …

By Sykes24Tracey

Mitalipov successfully repairs genes in human embryos A ground breaking discovery by Shoukhrat Mitalipov, Ph.D.,was reported in Nature the successful removal of a lethal geneticdefect in human embryos.

To Read More: Center for Embryonic Cell and Gene Therapy | Center for …
categoriaIPS Cell Therapy commentoComments Off on Center for Embryonic Cell and Gene Therapy | Center for … | dataAugust 30th, 2017
Read All

Buy brand levitra online – Bayer brand levitra online – Forward Florida

By JoanneRUSSELL25

Forward Florida Buy brand levitra online – Bayer brand levitra online Forward Florida Brand levitra price weight to Platinum your that brand its options I and disease.

To Read More: Buy brand levitra online – Bayer brand levitra online – Forward Florida
categoriaIPS Cell Therapy commentoComments Off on Buy brand levitra online – Bayer brand levitra online – Forward Florida | dataAugust 30th, 2017
Read All

Wasteful spending on medical public works – The Japan Times

By NEVAGiles23

Social security expenditures keep rising endlessly as the aging of Japans population accelerates with the low birthrate.

To Read More: Wasteful spending on medical public works – The Japan Times
categoriaIPS Cell Therapy commentoComments Off on Wasteful spending on medical public works – The Japan Times | dataAugust 28th, 2017
Read All

Buying kamagra jelly – Kamagra oral jelly user reviews – Laughlin Entertainer

By NEVAGiles23

Theres a lot to be said for being in the right place at the right time, but could Air Supplys long-time success be the result or a chance meeting or was the cosmos working overtime on a little something called destiny? Maybe, but one thing is for surenone of it would have been possible at all without their hard work and tenacity to make it happen.The two Russells, Graham Russell and Russell Hitchcock, happened to be cast in the same Sydney, Australian production of Jesus Christ Superstar in 1975, and everything changed after that

To Read More: Buying kamagra jelly – Kamagra oral jelly user reviews – Laughlin Entertainer
categoriaIPS Cell Therapy commentoComments Off on Buying kamagra jelly – Kamagra oral jelly user reviews – Laughlin Entertainer | dataAugust 26th, 2017
Read All

For Immune System Stem Cell Studies, Mice Aren’t Enough – Science 2.0

By admin

For Immune System Stem Cell Studies, Mice Aren't Enough Science 2.0 Stem cell therapy is all the rage, with suspect companies sprouting up like supplement stores, claiming to be a benefit for this and that. Often all they have are mouse studies and FDA disclaimers on ..

To Read More: For Immune System Stem Cell Studies, Mice Aren’t Enough – Science 2.0
categoriaIPS Cell Therapy commentoComments Off on For Immune System Stem Cell Studies, Mice Aren’t Enough – Science 2.0 | dataAugust 24th, 2017
Read All

An Experts Perspective on Accelerated Pathways for Cell …

By LizaAVILA

Yaron Ramati, Director of Regulatory Affairs at Pluristem Therapeutics Over the past few years, the regulatory landscape for cell therapy development has grown increasingly complex. There are now accelerated pathways for advanced therapy medicinal products (ATMPs) in several countries worldwide, including the U.S., Japan, and South Korea.

To Read More: An Experts Perspective on Accelerated Pathways for Cell …
categoriaIPS Cell Therapy commentoComments Off on An Experts Perspective on Accelerated Pathways for Cell … | dataAugust 20th, 2017
Read All

Stem Cell Glossary

By admin

Stem cell science involves many technical terms.

To Read More: Stem Cell Glossary
categoriaIPS Cell Therapy commentoComments Off on Stem Cell Glossary | dataAugust 19th, 2017
Read All

Daiichi Sankyo hearts Cuorips – Global University Venturing

By LizaAVILA

Cuorips, a Japan-based cardiac therapy developer spun out from Osaka University, has secured an undisclosed amount from pharmaceutical firm Daiichi Sankyo. The investment was made as part of an agreement that gives the corporate an option right for the worldwide commercialisation of Cuorips technology, called iPS-derived cardiomyocyte sheet, a cell therapy for patients suffering from severe heart failure.

To Read More: Daiichi Sankyo hearts Cuorips – Global University Venturing
categoriaIPS Cell Therapy commentoComments Off on Daiichi Sankyo hearts Cuorips – Global University Venturing | dataAugust 11th, 2017
Read All

Daiichi Sankyo signs Investment contract with Cuorips to commercialize iPS-derived cardiomyocyte sheet – pharmabiz.com

By raymumme

Daiichi Sankyo Company has signed an investment contract with Cuorips Inc., an Osaka University spin-off venture to receive an option right concerning the worldwide commercialization of iPS-derived cardiomyocyte (iPS-CM) sheet developed by Cuorips. The iPS-CM sheet is an allogeneic cell therapy product consisting of cardiomyocyte derived from human iPS cells.

To Read More: Daiichi Sankyo signs Investment contract with Cuorips to commercialize iPS-derived cardiomyocyte sheet – pharmabiz.com
categoriaIPS Cell Therapy commentoComments Off on Daiichi Sankyo signs Investment contract with Cuorips to commercialize iPS-derived cardiomyocyte sheet – pharmabiz.com | dataAugust 8th, 2017
Read All

Daiichi Sankyo invests in Osaka University spin-off – The Pharma Letter (registration)

By admin

Japanese pharma major Daiichi Sankyo (TYO: 4568) revealed this morning that it has signed an investment contract with Cuorips Inc, an Osaka University spin-off venture to receive an option right concerning the worldwide commercialization of iPS-derived cardiomyocyte (iPS-CM) sheet developed by Cuorips. The iPS-CM sheet is an allogeneic cell therapy product consisting of cardiomyocyte derived from human iPS cells

To Read More: Daiichi Sankyo invests in Osaka University spin-off – The Pharma Letter (registration)
categoriaIPS Cell Therapy commentoComments Off on Daiichi Sankyo invests in Osaka University spin-off – The Pharma Letter (registration) | dataAugust 7th, 2017
Read All

Affimed Therapeutics’ (AFMD) CEO Adi Hoess on Q2 2017 Results – Earnings Call Transcript – Seeking Alpha

By daniellenierenberg

Affimed Therapeutics (NASDAQ:AFMD) Q2 2017 Earnings Conference Call August 1, 2017 8:30 AM ET Executives Anca Alexandru Head of Communications Adi Hoess Chief Executive Officer Florian Fischer Chief Financial Officer Analysts Maury Raycroft Jefferies Do Kim BMO Capital Markets Michael Schmidt Leerink Peter Lawson SunTrust Operator Good day and welcome to the Affimed Second Quarter 2017 Financial Results and Corporate Update Conference Call. Todays conference is being recorded.

To Read More: Affimed Therapeutics’ (AFMD) CEO Adi Hoess on Q2 2017 Results – Earnings Call Transcript – Seeking Alpha
categoriaIPS Cell Therapy commentoComments Off on Affimed Therapeutics’ (AFMD) CEO Adi Hoess on Q2 2017 Results – Earnings Call Transcript – Seeking Alpha | dataAugust 5th, 2017
Read All

High-tech solutions top the list in the fight against eye disease – Engadget

By daniellenierenberg

Cataracts are the single leading cause of blindness worldwide, afflicting roughly 42 percent of the global population, including more than 22 million Americans. The disease, which causes cloudy patches to form on the eye’s normally clear lens, can require surgery if left untreated. That’s why Google’s DeepMind AI division has teamed with the UK’s National Health Service (NHS) and Moorfields Eye Hospital to train a neural network that will help doctors diagnose early stage cataracts.

To Read More: High-tech solutions top the list in the fight against eye disease – Engadget
categoriaIPS Cell Therapy commentoComments Off on High-tech solutions top the list in the fight against eye disease – Engadget | dataJuly 13th, 2017
Read All